Morphosys definition

Morphosys means Morphosys AG, a German stock corporation having its principal place of business at Xxxx-Xxxxxx-Xxxxxxx 00, 00000 Xxxxxxxxxxx/Xxxxxxx, Xxxxxxx.
Morphosys for the purpose of this EXHIBIT 16, including its Annexes, shall mean MorphoSys AG only. In case of any conflicts or inconsistencies between the terms of the Agreement and this EXHIBIT 16, the terms and conditions of this EXHIBIT 16 shall prevail with respect to the subject matter hereof. As at the Execution Date, the registered share capital of MorphoSys amounts to € 31,957,958, divided into 31,957,958 ordinary shares in bearer form with no par value and a notional value attributable to each share of €1.00 (the "Existing Shares"). All Existing Shares of MorphoSys are admitted to trading on the regulated market (regulierter Markt) and to the sub-segment of the regulated market with additional obligations arising from admission (Prime Standard) on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse).

Examples of Morphosys in a sentence

  • Hoffmann-La Roche, BBT, Bicycle therapeu- tics, Morphosys and Ioncturas.

  • In addition, within a period of [***] after the Effective Date (unless the Parties agree to extend such period), Novartis shall enable Buyer to negotiate with Morphosys a direct license to replace this Agreement.

  • Buyer may sublicense its rights under this Section 2.1 to Bona Fide Collaborators as permitted under the Morphosys Agreement.

  • In full consideration for the rights granted to Buyer hereunder, and solely to the extent Novartis is required to make such payments to Morphosys, Buyer hereby agrees to make the following payments to Novartis: [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.

  • Minimum and ‘Actual’ Wages, Plant-Level Bargaining, and Productivity Agreements As the discussion in the historical section above indicated, the unions that emerged after 1973 sought to bargain at industrial council and plant-levels.

  • On 30 November 2017, Morphosys (Planegg) signed a regional license agreement for antibody MOR202 (anti- CD38 antibody) with I-Mab.

  • Novartis hereby grants to Buyer the benefits of the covenant-not-to-xxx (“CAT Covenant”) under a framework agreement between Morphosys and Cambridge Antibody Technology (“CAT Framework Agreement”), with regard to the “CAT Patent Rights” described in Appendix 3.02 of the CAT Framework Agreement, in order to permit Buyer to practice any licenses granted to it herein by Novartis.

  • Moroney from Morphosys AG claims that “from our perspective the most successful collaborations are the ones that are a fair deal and motivate” (Interview on April 17, 2003) as well as S.

  • This Agreement shall be effective as of the Effective Date and shall continue, unless terminated earlier pursuant to this Article XI, until the earlier of: (a) termination of the Morphosys Agreement; or (b) on a product-by-product, country-by-country basis in accordance with its terms until, with respect to a Therapeutic Antibody Product in a particular country, the expiration of such Therapeutic Antibody Product’s Royalty Term in such country (the “Term”).

  • Phage display platforms include the Dyax non-immune Fab library, the Morphosys HuCAL synthetic Fab library, and the MedImmune non-immune scFv library.

Related to Morphosys

  • ISIS means the department’s individualized services information system.

  • GSK will have the meaning set forth in the Preamble.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Novartis shall have the meaning set forth in the Preamble.

  • Merck has the meaning set forth in the preamble.

  • Collaborator An individual who is not under the direct supervision of the PI (e.g., not a member of the PI’s laboratory) who assists with the PI’s research project involving controlled-access data subject to the NIH GDS Policy. Internal collaborators are employees of the Requester and work at the same location/campus as the PI. External collaborators are not employees of the Requester and/or do not work at the same location as the PI, and consequently must be independently approved to access controlled-access data subject to the NIH GDS Policy.

  • Licensee has the meaning set forth in the preamble.

  • the Licensee means the person(s) named in the licence.

  • Pfizer shall have the meaning set forth in the preamble.

  • HPA means the Current HPA, as further amended by this Fourth Amendment.

  • Lilly has the meaning set forth in the Preamble.

  • Research Program has the meaning set forth in Section 2.1.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Research Program Term has the meaning set forth in Section 2.2.

  • Sublicensee means a third party to whom LICENSEE grants a sublicense of certain rights granted to LICENSEE under this Agreement.

  • PTC means the tax credit for electricity produced from certain renewable generation resources described in Section 45 of the Internal Revenue Code of 1986, as it may be amended or supplemented from time to time.

  • PHS means the U.S. Public Health Service, an operating component of the DHHS.

  • Licensor Technology means the Licensor Patents and the Licensor Know-How.

  • Licensee Technology means the Licensee Know-How and Licensee Patents.

  • Licensed Compound means [***].

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Licensor means the copyright owner or entity authorized by the copyright owner that is granting the License.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration has the meaning set forth in Section 2.1.